Connect Biopharma Holdings (Connect Biopharma Holdings) Total Liabilities : $24.85 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Connect Biopharma Holdings Total Liabilities?

Connect Biopharma Holdings's Total Liabilities for the quarter that ended in Dec. 2023 was $24.85 Mil.

Connect Biopharma Holdings's quarterly Total Liabilities declined from Dec. 2022 ($16.52 Mil) to Jun. 2023 ($15.36 Mil) but then increased from Jun. 2023 ($15.36 Mil) to Dec. 2023 ($24.85 Mil).

Connect Biopharma Holdings's annual Total Liabilities declined from Dec. 2021 ($18.80 Mil) to Dec. 2022 ($16.52 Mil) but then increased from Dec. 2022 ($16.52 Mil) to Dec. 2023 ($24.85 Mil).

Connect Biopharma Holdings Total Liabilities Historical Data

The historical data trend for Connect Biopharma Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Connect Biopharma Holdings Total Liabilities Chart

Connect Biopharma Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

95.88

322.93

18.80

16.52

24.85

Connect Biopharma Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial				18.80	21.73	16.52	15.36	24.85

Connect Biopharma Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Connect Biopharma Holdings's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	24.264	+	(0.18	+	8.3266726846887E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.405	+	0)
	=	24.85

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	125.892	-	101.043
	=	24.85

Connect Biopharma Holdings's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	24.264	+	(0.18	+	8.3266726846887E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.405	+	0)
	=	24.85

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	125.892	-	101.043
	=	24.85

Connect Biopharma Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Connect Biopharma Holdings (Connect Biopharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

12265 El Camino Real, Suite 350, San Diego, CA, USA, 92130

Website

https://www.connectbiopharm.com

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.